Market News

Gabelli Funds Lifted Pandora Media Com (P) Position By $1.74 Million; Depomed (DEPO) Sentiment Is 1.36

Depomed, Inc. (NASDAQ:DEPO) Logo

Gabelli Funds Llc increased Pandora Media Inc Com (P) stake by 31.8% reported in 2018Q1 SEC filing. Gabelli Funds Llc acquired 347,000 shares as Pandora Media Inc Com (P)’s stock rose 55.78%. The Gabelli Funds Llc holds 1.44M shares with $7.23M value, up from 1.09 million last quarter. Pandora Media Inc Com now has $2.15 billion valuation. The stock increased 1.38% or $0.11 during the last trading session, reaching $8.08. About 2.84M shares traded. Pandora Media, Inc. (NYSE:P) has declined 23.47% since June 18, 2017 and is downtrending. It has underperformed by 36.04% the S&P500. Some Historical P News: ; 11/05/2018 – Cove Street Capital Buys New 1.1% Position in Pandora Media; 24/05/2018 – PANDORA PRICES CONV NOTE EXCHANGE TRANSACTIONS; 15/05/2018 – CHINA TELLS WORLD TRADE ORGANIZATION DISPUTE PANEL THAT EUROPEAN UNION IS OPENING PANDORA’S BOX BY DENYING CHINA’S MARKET ECONOMY STATUS – STATEMENT; 21/03/2018 – Pandora To Buy Digital Audio Advertising Business for $145M; 15/05/2018 – PANDORA CEO SAYS EXPECTS TO RETURN TO POSITIVE LIKE-FOR-LIKE SALES GROWTH IN CHINA THIS YEAR; 29/03/2018 – China warns US not to open Pandora’s Box and unleash a trade war on the world; 19/04/2018 – MC Endeavors, Inc./Room 21 Media, Inc. (MSMY) Announces Letter of Intent to Acquire New Production Studios for TheShare.TV; 15/05/2018 – Pandora Backs 2018 Guidance; 03/05/2018 – Pandora Media 1Q Rev $319.2M; 24/05/2018 – PANDORA TRANSACTION EXTENDS MATURITY OF $192.9M SR CONV NOTES

Depomed Inc (DEPO) investors sentiment increased to 1.36 in Q1 2018. It’s up 0.43, from 0.93 in 2017Q4. The ratio is positive, as 75 hedge funds increased or opened new equity positions, while 55 cut down and sold holdings in Depomed Inc. The hedge funds in our database now possess: 60.75 million shares, up from 55.87 million shares in 2017Q4. Also, the number of hedge funds holding Depomed Inc in top ten equity positions was flat from 1 to 1 for the same number . Sold All: 15 Reduced: 40 Increased: 46 New Position: 29.

Since February 16, 2018, it had 0 insider buys, and 12 sales for $1.09 million activity. Phillips Christopher W sold $161,652 worth of stock or 22,083 shares. Robinson Kristen sold $322,770 worth of stock. BENE STEPHEN G also sold $57,033 worth of Pandora Media, Inc. (NYSE:P) shares. 7,997 shares valued at $59,154 were sold by Trimble John on Wednesday, May 16. GERBITZ DAVID sold 7,082 shares worth $52,386. $86,271 worth of Pandora Media, Inc. (NYSE:P) was sold by Walker Karen Sammis on Wednesday, May 16.

Gabelli Funds Llc decreased Integer Holdings Corp stake by 38,208 shares to 147,792 valued at $8.36M in 2018Q1. It also reduced Morgan Stanley (NYSE:MS) stake by 38,500 shares and now owns 441,952 shares. Biogen Idec Inc (NASDAQ:BIIB) was reduced too.

Among 40 analysts covering Pandora Media (NYSE:P), 15 have Buy rating, 2 Sell and 23 Hold. Therefore 38% are positive. Pandora Media had 157 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Thursday, May 11 by JMP Securities. The firm earned “Hold” rating on Friday, November 3 by Stifel Nicolaus. The firm has “Outperform” rating by BMO Capital Markets given on Thursday, November 16. FBR Capital maintained Pandora Media, Inc. (NYSE:P) on Monday, June 26 with “Buy” rating. The firm has “Neutral” rating by Mizuho given on Wednesday, September 14. SunTrust upgraded the stock to “Buy” rating in Friday, May 4 report. The stock of Pandora Media, Inc. (NYSE:P) earned “Sector Perform” rating by Scotia Capital on Tuesday, June 14. The stock of Pandora Media, Inc. (NYSE:P) has “Sector Perform” rating given on Friday, October 23 by RBC Capital Markets. The rating was maintained by Needham on Tuesday, September 22 with “Buy”. The stock of Pandora Media, Inc. (NYSE:P) has “Buy” rating given on Wednesday, June 14 by Needham.

More important recent Pandora Media, Inc. (NYSE:P) news were published by: Seekingalpha.com which released: “Pandora Climbs On Social Media Move” on June 15, 2018, also Benzinga.com published article titled: “This Day In Market History: Pandora Goes Public”, Finance.Yahoo.com published: “A Deal with SNAP Could Be Just What Pandora Media Inc. Stock Needed” on June 17, 2018. More interesting news about Pandora Media, Inc. (NYSE:P) was released by: Investorplace.com and their article: “How to Profit From the Inevitable End to Snap Inc’s Comeback” with publication date: June 18, 2018.

Investors sentiment increased to 1.5 in Q1 2018. Its up 0.46, from 1.04 in 2017Q4. It improved, as 35 investors sold P shares while 39 reduced holdings. 40 funds opened positions while 71 raised stakes. 239.08 million shares or 2.22% more from 233.88 million shares in 2017Q4 were reported. State Board Of Administration Of Florida Retirement reported 0.01% of its portfolio in Pandora Media, Inc. (NYSE:P). Wellington Management Grp Llp reported 783,040 shares or 0% of all its holdings. Geode Capital Mgmt Ltd Liability Corp, a Massachusetts-based fund reported 2.04 million shares. First Trust Advsr Lp has 13.52 million shares. Price Michael F, New York-based fund reported 395,000 shares. Oz Management LP has 78,300 shares. Slate Path Capital Limited Partnership reported 7.32 million shares or 2.35% of all its holdings. Utah Retirement has 44,786 shares. Virtu Ltd Limited Liability Company holds 0.08% of its portfolio in Pandora Media, Inc. (NYSE:P) for 300,681 shares. Ws Mgmt Lllp stated it has 1.47M shares. Teton Advsrs invested in 183,163 shares or 0.09% of the stock. Baker Avenue Asset Limited Partnership has 18,531 shares for 0.01% of their portfolio. Jane Street Grp Inc Ltd Liability Company has invested 0% in Pandora Media, Inc. (NYSE:P). Teacher Retirement System Of Texas reported 54,942 shares. Allen Management Limited Com owns 48,113 shares or 0.01% of their US portfolio.

Ratings analysis reveals 33% of DepoMed’s analysts are positive. Out of 3 Wall Street analysts rating DepoMed, 1 give it “Buy”, 1 “Sell” rating, while 1 recommend “Hold”. DEPO was included in 3 notes of analysts from September 19, 2016. The firm earned “Underweight” rating on Monday, December 12 by Piper Jaffray. Cantor Fitzgerald downgraded the shares of DEPO in report on Tuesday, November 8 to “Hold” rating. Mizuho maintained the stock with “Buy” rating in Monday, September 19 report.

Analysts await Depomed, Inc. (NASDAQ:DEPO) to report earnings on August, 6. They expect $-0.30 earnings per share, up 30.23% or $0.13 from last year’s $-0.43 per share. After $0.48 actual earnings per share reported by Depomed, Inc. for the previous quarter, Wall Street now forecasts -162.50% negative EPS growth.

Since January 1, 0001, it had 0 buys, and 2 selling transactions for $438,610 activity.

More recent Depomed, Inc. (NASDAQ:DEPO) news were published by: Seekingalpha.com which released: “The Jury’s Still Out On Depomed” on May 21, 2018. Also Nasdaq.com published the news titled: “Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)” on June 07, 2018. Nasdaq.com‘s news article titled: “Depomed Announces the Appointment of Phillip B. Donenberg as Chief Financial Officer” with publication date: June 05, 2018 was also an interesting one.

The stock increased 0.63% or $0.045 during the last trading session, reaching $7.165. About 362,393 shares traded. Depomed, Inc. (DEPO) has declined 38.98% since June 18, 2017 and is downtrending. It has underperformed by 51.55% the S&P500. Some Historical DEPO News: ; 09/04/2018 – Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4); 10/05/2018 – DepoMed 1Q EPS 48c; 02/04/2018 – DepoMed: Vetticaden to Remain With Company Through the End of April to Ensure a Smooth Transition; 19/03/2018 – Endo International, Depomed and Mallinckrodt all fell on the news; 22/05/2018 – DEPOMED HOLDER STARBOARD VALUE CUT STAKE; 14/05/2018 – STARBOARD VALUE LP REPORTS 6.1 PCT STAKE IN DEPOMED INC AS OF MAY 10, 2018 – SEC FILING; 10/05/2018 – DepoMed Sees FY Loss $23M-Loss $33; 14/05/2018 – Allianz Global Investors US Buys New 43% Position in Depomed; 10/05/2018 – DEPOMED INC – CONFIRMS PREVIOUS 2018 GUIDANCE FOR NEUROLOGY FRANCHISE NET SALES AND NON-GAAP ADJUSTED EBITDA; 21/05/2018 – Depomed Forms Golden Cross: Technicals

Armistice Capital Llc holds 2.71% of its portfolio in Depomed, Inc. for 5.38 million shares. Opaleye Management Inc. owns 600,000 shares or 1.13% of their US portfolio. Moreover, Deltec Asset Management Llc has 1.01% invested in the company for 769,293 shares. The New York-based Starboard Value Lp has invested 0.66% in the stock. Perkins Capital Management Inc, a Minnesota-based fund reported 89,450 shares.

Depomed, Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. The company has market cap of $455.60 million. It offers Gralise , an once-daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults. It currently has negative earnings. The firm also provides NUCYNTA ER (tapentadol extended release tablets), a product for the management of pain severe enough to long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults; and NUCYNTA (tapentadol), a product for the management of moderate to severe acute pain in adults.

Pandora Media, Inc. (NYSE:P) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *